Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L, Bossi P, Locati L, Canevari S, Licitra L. De Cecco L, et al. Ann Oncol. 2014 Aug;25(8):1628-35. doi: 10.1093/annonc/mdu173. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827125
CONCLUSIONS: We have identified and validated a prognostic model based on the expression of 172 genes, independent from HPV status and able to improve assessment of patient's risk of relapse compared with other molecular signatures. ...
CONCLUSIONS: We have identified and validated a prognostic model based on the expression of 172 genes, independent from HPV status and able …
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A, Nicoletti R, Tinaglia V, De Cecco L, Pisanu ME, Ricci A, Podo F, Canevari S, Iorio E, Bagnoli M, Mezzanzanica D. Granata A, et al. Br J Cancer. 2014 Jan 21;110(2):330-40. doi: 10.1038/bjc.2013.729. Epub 2013 Nov 26. Br J Cancer. 2014. PMID: 24281000 Free PMC article.
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, Canevari S, Tomassetti A. Alberti C, et al. Oncogene. 2012 Sep 13;31(37):4139-49. doi: 10.1038/onc.2011.572. Epub 2011 Dec 12. Oncogene. 2012. PMID: 22158046
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Machiels JP, Bossi P, Menis J, Lia M, Fortpied C, Liu Y, Lhommel R, Lemort M, Schmitz S, Canevari S, De Cecco L, Guzzo M, Bianchi R, Quattrone P, Crippa F, Duprez T, Lalami Y, Quiriny M, de Saint Aubain N, Clement PM, Coropciuc R, Hauben E, Licitra LF. Machiels JP, et al. Ann Oncol. 2018 Apr 1;29(4):985-991. doi: 10.1093/annonc/mdy013. Ann Oncol. 2018. PMID: 29346507 Clinical Trial.
Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle.
Frigerio B, Morlino S, Luison E, Seregni E, Lorenzoni A, Satta A, Valdagni R, Bogni A, Chiesa C, Mira M, Canevari S, Alessi A, Figini M. Frigerio B, et al. Among authors: canevari s. J Exp Clin Cancer Res. 2019 Jul 23;38(1):326. doi: 10.1186/s13046-019-1325-6. J Exp Clin Cancer Res. 2019. PMID: 31337429 Free PMC article.
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.
Frigerio B, Fracasso G, Luison E, Cingarlini S, Mortarino M, Coliva A, Seregni E, Bombardieri E, Zuccolotto G, Rosato A, Colombatti M, Canevari S, Figini M. Frigerio B, et al. Eur J Cancer. 2013 Jun;49(9):2223-32. doi: 10.1016/j.ejca.2013.01.024. Epub 2013 Feb 20. Eur J Cancer. 2013. PMID: 23433847
A step further in understanding the biology of the folate receptor in ovarian carcinoma.
Bagnoli M, Canevari S, Figini M, Mezzanzanica D, Raspagliesi F, Tomassetti A, Miotti S. Bagnoli M, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S140-4. doi: 10.1006/gyno.2002.6705. Gynecol Oncol. 2003. PMID: 12586106 Review. No abstract available.
238 results
Jump to page